SCOTCERV: A phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer

Symonds, R.P., Davidson, S.E., Chan, S., Reed, N.S., McMahon, T., Rai, D., Harden, S. and Paul, J. (2011) SCOTCERV: A phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer. Gynecologic Oncology, 123(1), pp. 105-109. (doi:10.1016/j.ygyno.2011.06.001)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1016/j.ygyno.2011.06.001


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Paul, Mr James
Authors: Symonds, R.P., Davidson, S.E., Chan, S., Reed, N.S., McMahon, T., Rai, D., Harden, S., and Paul, J.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
Journal Name:Gynecologic Oncology
ISSN:0090-8258

University Staff: Request a correction | Enlighten Editors: Update this record